News & Events
Grants last few years
NIH/NIDDK Phase II SBIR awarded Sept 2015
Human induced pluripotent stem cell-derived beta-cells for drug and toxicity testing.
NIH/NIDDK Phase 1 SBIR awarded July 2016
Diabetes drug screening platforms using patient pancreatic islet-like cells generated from induced pluripotent stem cells.
NIH/NIDDK Phase I SBIR awarded Sept 2016
Development of a rapid and inexpensive luciferase-based high throughput screening assay to identify compounds that alter pancreatic β cell function.
NIH/NIDDK Phase I SBIR awarded Sept 2016
Engineered pancreatic endocrine cells that report beta cell toxicity for use in high throughput screening applications.
WI SBIR Advance awarded 2017
WI SBIR Advance awarded 2017
